Core Viewpoint - The pricing power battle in the medical aesthetics industry is intensifying, with New Oxygen (SY.O) challenging upstream manufacturers over the pricing of its "youthful needle" products, leading to significant price reductions and disputes regarding product sourcing and compliance [1][2][3]. Group 1: Pricing Strategy and Market Dynamics - New Oxygen launched its "Miracle Youth 1.0" at a price of 4,999 yuan per unit, marking the first time the market price for youthful needles reached the 5,000 yuan range, while the manufacturer's price was 16,800 yuan per unit [1]. - In June, New Oxygen introduced "Miracle Youth 2.0" at 5,999 yuan per unit, using a product from Saint Boma, which has a market average price of approximately 18,800 yuan per unit [1]. - On December 15, New Oxygen's youth clinics offered a group purchase price as low as 949 yuan per unit, representing a drastic reduction of about 95% compared to the manufacturer's controlled price of 16,800-18,800 yuan per unit [2]. Group 2: Manufacturer Responses and Industry Implications - Multiple upstream manufacturers have publicly distanced themselves from New Oxygen, with Fiman Bio announcing it ceased supplying products to New Oxygen and its clinics, warning that continued sales could indicate non-compliance or counterfeit products [2]. - New Oxygen argues that the ongoing pricing battle reflects a structural shift in the medical aesthetics market from a "seller's market" to a "buyer's market," driven by the approval of more products like youthful needles and hyaluronic acid [2]. - The company believes that a rational price return will benefit both upstream and downstream players, allowing for stable orders that can reduce production and R&D costs, while also fostering healthier customer acquisition and repurchase models [3].

Core Viewpoint - The conflict between medical beauty platform Xinyang (SY.US) and upstream supplier of regenerative materials has escalated, with accusations regarding product sourcing and training practices [2][3] Pricing Strategy and Supply Chain Conflict - In April 2025, Xinyang launched "Miracle Youth 1.0," pricing the product at 4,999 yuan per unit, significantly lower than the supplier's guidance price of 16,800 yuan [3] - In June 2025, Xinyang's "Miracle Youth 2.0" used a product from Saint Boma, priced at 5,999 yuan, while the market average was approximately 18,800 yuan, leading to accusations of unauthorized procurement [3] Company Response and Compliance - Xinyang stated that all medical devices are sourced from legally qualified suppliers with complete traceable purchase documentation, and all clinics are legally established medical institutions [5] - The company emphasized that the era of market monopoly through registration certificate scarcity and excessive price control has ended, attributing low prices to value return through large-scale procurement and reduced marketing costs [5] Financial Performance and Transition Challenges - Xinyang, as the "first internet medical beauty stock," faces strong competition from platforms like Douyin, Xiaohongshu, and Meituan, resulting in a 19.3% year-on-year decline in information and appointment service revenue in 2024 [6] - In the first three quarters of 2025, Xinyang's revenue reached 1.063 billion yuan, a decrease of 3.36% year-on-year, with a net loss of 133 million yuan, marking a shift from profit to loss [6] - The company's offline beauty treatment services generated 427 million yuan, a 385.05% increase year-on-year, becoming the largest revenue source, surpassing traditional business for the first time [6] Industry Competition and Business Model Changes - Xinyang's aggressive pricing strategy has led to a significant reduction in profit margins, with offline service gross margins dropping to 24%, well below the industry average of over 50% [7] - In September 2025, Xinyang launched a customized version of "Plastic Beauty" (Miracle Youth 3.0) at a price of 2,999 yuan, with a core ingredient PLLA content of 75mg, only half of that in mainstream products [7] - The company's "low-price revolution" and aggressive transformation have fundamentally changed its business model, raising concerns about balancing price competitiveness with supply chain relationships and ensuring medical safety and service quality [7]

Group 1 - The compliance process for medical beauty water light needles is accelerating, with Meituan Medical Beauty launching a dedicated area for compliant products and services [1] - Meituan has implemented various measures to promote compliance in the medical beauty industry, including the "Safe Beauty" system that utilizes AIoT technology for product verification and traceability [4] - As of June 2025, Meituan's "Safe Beauty" initiative has provided over 7 million verification services across 100 cities, supporting more than 2,000 medical beauty institutions with over 4,000 smart verification devices [4] Group 2 - Meituan has introduced the "Safe Beauty · Worry-Free Guarantee" service model, focusing on doctor-led solutions that ensure transparent pricing and guaranteed results for anti-aging and shaping experiences [4] - The company has established the Polaris Medical Beauty Ranking, evaluating institutions based on 140 criteria to help users select high-quality medical beauty providers [5] - The 2025 Polaris Medical Beauty Ranking will merge the institution and doctor rankings to provide a comprehensive guide for users, featuring 152 institutions and 240 doctors from various cities [5]